ID   U268
AC   CVCL_W412
SY   U-268; 268 Bm
DR   Wikidata; Q54973649
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=4097745;
RX   PubMed=4104421;
RX   PubMed=10936422;
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JA36 ! U255
OI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=4097745;
RA   Nilsson K., Bennich H., Johansson S.G.O., Ponten J.;
RT   "Established immunoglobulin producing myeloma (IgE) and lymphoblastoid
RT   (IgG) cell lines from an IgE myeloma patient.";
RL   Clin. Exp. Immunol. 7:477-489(1970).
//
RX   PubMed=4104421; DOI=10.1002/ijc.2910070303;
RA   Nilsson K.;
RT   "Characteristics of established myeloma and lymphoblastoid cell lines
RT   derived from an E myeloma patient: a comparative study.";
RL   Int. J. Cancer 7:380-396(1971).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//